Search Results
Feb 26, 2026, 16:15 ET AAR signs new agreement with Otto Instrument Service
Instrument Service, Inc., founded in 1946, is a leading provider of maintenance, repair, and overhaul ("MRO") services for commercial, cargo, air transport (ATR), business general aviation (BGA), military, and fixed wing and rotary wing aircraft operators worldwide. As one of the few remaining privately held
More news about: AAR CORP.
Feb 25, 2026, 11:01 ET Accelint Partners with NODA AI, Safran Federal Systems, and Striveworks to Deliver Integrated USV Capabilities for Naval Operations
multiplier for naval operations. The MV-20 integrates Striveworks' AI Operation platform - which includes its sensor-agnostic automated target recognition (ATR) technology, Safran Federal Systems' electronic warfare and assured positioning navigation, and timing (APNT) capabilities, alongside NODA AI's orchestration
More news about: Accelint
Feb 25, 2026, 08:50 ET Leonardo Selects Pegasus Next-Generation Rescue Hoist from Onboard Systems Hoist & Winch for AW139 and Future Platforms
the UK, Poland, and the USA. Leonardo utilises its subsidiaries, joint ventures, and shareholdings, which include Leonardo DRS (71.4%), MBDA (25%), ATR (50% ), Hensoldt (22.8%), Telespazio (67%), Thales Alenia Space (33%), and Avio (19.3%). Listed on the Milan Stock Exchange (LDO), in 2024 Leonardo recorded
More news about: Onboard Systems Hoist & Winch
Feb 24, 2026, 08:00 ET Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash
trial for our ATR-12, (ii) the development for the Phase 1/2 clinical trial for our ATR-04 program and the initiation of dosing and anticipated enrollment in the Phase 1/2 clinical trial for our ATR-04 program, and (iii) statements about our clinical and preclinical programs, including ATR-01, and corporate
More news about: Azitra, Inc.
Feb 19, 2026, 08:00 ET Azitra, Inc. to Present at BIO Investment & Growth Summit
clinical trial for our ATR-12, (ii) the development for the Phase 1/2 clinical trial for our ATR-04 program and the initiation of dosing in the Phase 1/2 clinical trial for our ATR-04 program, and (iii) statements about our clinical and preclinical programs, including ATR-01, and corporate and clinical/preclinical
More news about: Azitra, Inc.
Feb 18, 2026, 12:43 ET Shrub Oak International School Announces Promotion of Laura Meyers, LCAT, ATR-BC, to Director of The Pines at Shrub Oak
Feb. 18, 2026 /PRNewswire/ -- Shrub Oak International School is pleased to announce the promotion of Laura Meyers, LCAT, ATR-BC, to Director of The Pines at Shrub Oak, a specialized therapeutic residential program serving neurodiverse children, adolescents, and young adults who
More news about: Shrub Oak International School
Feb 18, 2026, 10:41 ET Reliability Roadmap by the Numbers: 2,700 Electric Reliability Improvements Powered by Customers' Investments in 2025
caused by falling branches, reduce storm damage and improve safetyUsed automated technology to reroute power during outages by creating 31 ATR loops including 96 reclosers to limit customer impact and outage length."We know customers are feeling the impact of rising costs
More news about: Consumers Energy
Feb 16, 2026, 03:21 ET Ericsson, Leonardo and Italian Navy trial 5G Standalone on-sea capabilities
the UK, Poland, and the USA. Leonardo utilises its subsidiaries, joint ventures, and shareholdings, which include Leonardo DRS (71.4%), MBDA (25%), ATR (50% ), Hensoldt (22.8%), Telespazio (67%), Thales Alenia Space (33%), and Avio (19.3%). Listed on the Milan Stock Exchange (LDO), in 2024 Leonardo recorded
More news about: Ericsson
Feb 16, 2026, 03:17 ET Ericsson, Leonardo and Italian Navy trial 5G Standalone on-sea capabilities
the UK, Poland, and the USA. Leonardo utilises its subsidiaries, joint ventures, and shareholdings, which include Leonardo DRS (71.4%), MBDA (25%), ATR (50% ), Hensoldt (22.8%), Telespazio (67%), Thales Alenia Space (33%), and Avio (19.3%). Listed on the Milan Stock Exchange (LDO), in 2024 Leonardo recorded
More news about: Ericsson
Feb 06, 2026, 16:15 ET Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
for EGFRi associated rash, which impacts approximately 150,000 people in the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic
More news about: Azitra, Inc.
Feb 04, 2026, 12:06 ET Methanol Market to Surpass USD 64.72 Billion by 2032, Driven by Green Methanol Demand and Clean Fuel Transition: Maximize Market Research
ProductionNatural Gas-Based MethanolSteam Methane Reforming (SMR)Autothermal Reforming (ATR)Coal-Based MethanolCoal GasificationIntegrated Methanol SynthesisLow-Carbon
More news about: Maximize Market Research Pvt. Ltd.
Jan 26, 2026, 09:00 ET HYCO1 Announces Three U.S. Patents Powering the Most Advanced Syngas Production Platform through CO₂ Utilization
efficiency builds.Advancing Industrial Gas Reforming and CO₂ utilizationHYCO1's patented approach improves SMR/ATR performance by enabling lower methane feed costs, reduced energy use, increased output from less gas input, non-coking operation, and better reactivity.
More news about: HYCO1
Jan 26, 2026, 02:44 ET Elbit Systems Awarded $228 Million Follow-on Contract to Provide Iron Fist APS for U.S. Army Bradley IFV Upgrades
low volume, weight and power requirements. The system delivers 360-degree protection against various anti-armor threats, including Anti-Tank Rockets (ATR), Anti-Tank Guided Missiles (ATGM), Unmanned Aerial Systems (UAS), loitering munitions, and Kinetic-Energy (APFSDS) tank ammunition, in both open terrain
More news about: Elbit Systems Ltd.
Jan 12, 2026, 07:00 ET CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
DrugSorb®-ATR De Novo Pre-Submission Meeting scheduled with the FDA this month, with anticipated De Novo Application filing this quarter and regulatory decision in mid-2026Results of the pivotal STAR-T study for DrugSorb®-ATR have
More news about: Cytosorbents Corp
Jan 07, 2026, 08:00 ET Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference
initial safety data and topline results for the phase 1b trial for our ATR-12, (ii) the abstract detailing the Phase 1/2 clinical trial for our ATR-04 program, (iii) the initiation of dosing in the Phase 1/2 clinical trial for our ATR-04 program, and (iv) statements about our clinical and preclinical programs,
More news about: Azitra, Inc.
Jan 07, 2026, 01:00 ET Liz Goll Lerner's 'Divorce Well and Thrive®' empowers readers to turn divorce into a pathway to growth and healing
Goll Lerner, LCAT, LCPAT, LPC ATR-BCSoftcover | 6 x 9in | 116 pages | ISBN 9798765250594E-Book | 116 pages | ISBN 9798765250600Available at Amazon and Barnes & NobleAbout the AuthorLiz Goll Lerner, LCAT, LCPAT, LPC, ATR-BC, is the creator of the Divorce
More news about: Balboa Press
Dec 22, 2025, 09:01 ET interCaribbean Airways Launches New Nonstop Service from Tortola to Barbados and St. Maarten
invest in connectivity options for BVI residents and visitors."The expansion is supported by the airline's growing fleet, which now includes 11 ATR turboprop aircraft, enabling interCaribbean to serve more destinations with greater frequency.Flights are now available for booking at interCaribbean.com or
More news about: interCaribbean Airways
Dec 22, 2025, 08:25 ET interCaribbean Airways Announces Five New Non-Stop Routes from Barbados to Tortola-Providenciales-St Maarten -Ogle -Port of Spain
UK-flagged airline operates the 50-seat Embraer ERJ145 Regional Jet, the Bombardier CRJ900 and a fleet of turboprops, comprising the 68-seat ATR72, 48-seat ATR42s, 30-seat EMB120s, and 19-seat Twin Otters. With a network spanning Georgetown, Guyana, in the south, Barbados to the east, Havana, Cuba, to
More news about: interCaribbean Airways
Dec 17, 2025, 16:10 ET Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
for EGFRi associated rash, which impacts approximately 150,000 people in the U.S. Azitra has an open IND for its ATR-04 program in patients with EGFRi associated rash. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic
More news about: Azitra, Inc.
Dec 16, 2025, 02:00 ET Hamilton Launches GlucoSense, a First-of-Its-Kind, Real-Time, In Situ Glucose Sensor for Mammalian Cell Culture
mid-infrared ATR spectroscopy tuned to glucose-specific absorption features, avoiding the chemometric model-building required for spectroscopic platforms. A single-use semi-permeable membrane creates a small measurement chamber that blocks cells and particulates from reaching the diamond ATR element, preventing
More news about: Hamilton Company
Dec 10, 2025, 07:00 ET CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
cardiothoracic surgery. The Company is actively pursuing regulatory approval of DrugSorb-ATR with the U.S. FDA and will pursue regulatory approval with Health Canada with better visibility from the FDA. DrugSorb-ATR is not yet granted or approved in either the U.S. or Canada.The Company has numerous
More news about: Cytosorbents Corp
Nov 24, 2025, 09:00 ET Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules
initial safety data and topline results for the phase 1b trial for our ATR-12, (ii) the abstract detailing the Phase 1/2 clinical trial for our ATR-04 program, (iii) the initiation of dosing in the Phase 1/2 clinical trial for our ATR-04 program, and (iv) statements about our clinical and preclinical programs,
More news about: Azitra, Inc.
Nov 17, 2025, 17:42 ET Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
cardiothoracic surgery. The Company is actively pursuing regulatory approval of DrugSorb-ATR with the U.S. FDA and will pursue regulatory approval with Health Canada with better visibility from the FDA. DrugSorb-ATR is not yet granted or approved in either the U.S. or Canada. The
More news about: Cytosorbents Corp
Nov 13, 2025, 16:05 ET CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
FDA marketing approval of DrugSorb-ATR is achieved. The Company will have access to an additional $2.5 million in term loan capital with a further six-month extension of the interest-only period to the July 1, 2027 maturity date upon the U.S. FDA approval of DrugSorb-ATR in 2026. Under the terms of the
More news about: Cytosorbents Corp
Nov 12, 2025, 17:15 ET Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates
proven to be a positive period for Azitra, and we continue to look forward to showcasing the potential of our three development programs ATR-12, ATR-04, and ATR-01. All three programs were generated from our unique, proprietary platform to deliver engineered proteins using topical live biotherapeutic
More news about: Azitra, Inc.